Biology subjects

Barroso, K.

Publications and source records attributed to Barroso, K..

2 recordsLinked to original sources

bioRxiv2021

p97/VCP induces GLI1 to control XBP1-dependent endoplasmic reticulum stress transcriptional response

Upon accumulation of improperly folded proteins in the ER, an adaptive pathway named the UPR is triggered to restore ER homeostasis. The induction of stress genes controlling ER dynamics is a condition sine qua non for an effective UPR. Although this requirement has been extensively characterized, the transcriptional mechanism underlying this process remains in part elucidated. Here, we show that p97/VCP, an AAA+ ATPase known to modulate ER stress-induced gene expression, dynamically interacts with RUVBL2 and the mSin3A-HDAC1/2 complex. Further analysis of the mechanism defined a novel interplay between the aforementioned molecules and the transcription factor USF2 to control expression of GLI1, a primary effector of Hedgehog (Hh) signaling. Under basal conditions, GLI1 is repressed by RUVBL2-mSin3A-HDAC1/2 while upon ER stress GLI1 is induced through a mechanism requiring p97/VCP-mediated extraction of the repressor complex. Further analysis showed that GLI1 cooperate with ATF6f to activate the expression of XBP1, a transcription factor regulating the expression of genes controlling cellular stress response, under ER conditions. Overall, our work demonstrates that p97/VCP orchestrates the activation of GLI1 upon ER stress in a Hh ligand-independent fashion and defines the interplay between the newly identified p97/VCP-mSin3A-HDAC1/2 complex and the transcription factor USF2 as an essential player in this process.

cancer biology↗

bioRxiv2019

IRE1-UBE2D3 signaling controls the recruitment of myeloid cells to glioblastoma.

Tumor cells are exposed to intrinsic and environmental challenges that trigger endoplasmic reticulum (ER) homeostasis alteration, in turn leading to ER stress. To cope with this, tumor cells engage an adaptive signaling pathway, the unfolded protein response (UPR) thus promoting the acquisition of malignant features. As such, glioblastoma multiforme (GBM), the most aggressive primary brain tumors, exhibit constitutive UPR signals to sustain growth. Herein, we showed that signaling elicited by one of the UPR sensors, IRE1, promotes GBM tumor invasion, angiogenesis and infiltration by macrophages. Hence, high IRE1 activity in tumors predicts worse outcome. We further dissect IRE1-dependent mechanisms that shape the brain tumor immune microenvironment towards myeloid cells. We identify an IRE1-dependent signaling pathway that directly controls the expression/release of proinflammatory chemokines (CXCL2, IL6, IL8) leading to tumor cell-mediated chemoattraction of neutrophils and macrophages. This pathway requires XBP1 non-conventional mRNA splicing and XBP1s-dependent expression of the E2 ubiquitin enzyme UBE2D3. The latter contributes to the degradation of the NF{kappa}B inhibitor I{kappa}B, leading to the up-regulation of proinflammatory chemokines. Our work identifies a novel IRE1/UBE2D3 proinflammatory signaling axis instrumental to pro-tumoral immune regulation of GBM.

cancer biology↗